Stock RSLS RESHAPE LIFESCIENCES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. ReShape Lifesciences Inc.

Equities

RSLS

US76090R2004

Real-time Estimate Cboe BZX
Other stock markets
 08:37:48 27/06/2024 pm IST 		5-day change 1st Jan Change
0.2 USD +1.01% Intraday chart for ReShape Lifesciences Inc. +6.00% -20.02%
15/05 ReShape Lifesciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
15/05 Transcript : ReShape Lifesciences Inc., Q1 2024 Earnings Call, May 15, 2024

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Maxim Group Adjusts ReShape Lifesciences Price Target to $1.50 From $3, Maintains Buy Rating
MT
Alliance Global Adjusts Price Target on ReShape Lifesciences to $4.65 From $5.50, Reiterates Buy Rating
MT
Maxim Lowers Price Target for ReShape Lifesciences to $4 From $8, Maintains Buy Rating
MT
Alliance Global Adjusts Price Target on ReShape Lifesciences to $5.50 From $10.25, Reiterates Buy Rating
MT
RESHAPE LIFESCIENCES : Maxim Group Initiates Coverage on ReShape Lifesciences With Buy Rating, $8 Price Target
MT
RESHAPE LIFESCIENCES : Alliance Global Partners Adjusts ReShape Lifesciences PT to $13.75 From $18.50, Maintains Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RSLS Stock
  4. News ReShape Lifesciences Inc.
  5. Analyst Reco.